The intracellular signaling controlling neural stem/progenitor cell (NSC) self-renewal and neuronal/glial differentiation is not fully understood. We show here that Shp2, an introcellular tyrosine phosphatase with two SH2 domains, plays a critical role in NSC activities. Conditional 
INTRODUCTION
There is a gap in our understanding of the molecular link between cytoplasmic signals initiated by growth factors and the control of NSC activities. Signaling through the Mek-Erk pathway regulating the C/EBP family of transcription factors was shown to promote cortical neurogenesis from NSCs, while suppressing gliogenesis (20) . By contrast, activation of the Jak/Stat pathway promotes gliogenesis with concomitant suppression of neurogenesis (2, 15) .
Shp2, a Src-homology 2 domain (SH2)-containing tyrosine phosphatase, is a widely expressed intracellular enzyme that regulates signaling events downstream of several growth factor/cytokine receptors in various cell types (8, 18) . In previous experiments, we demonstrated a stringent requirement for Shp2 in hematopoiesis, using in vitro ESC differentiation assays and chimeric animal analysis (28-30). Shp2-deficient erythroid, myeloid or lymphoid progenitor cells are barely detectable in the fetal liver, bone marrow, thymus or spleen in the chimeric animals derived from aggregation of homozygous Shp2 mutant ESCs and wild-type embryos. However, it is interesting to note that Shp2-deficient cells were detected in many other non-hematopoietic tissues and organs, including the brain (29). This observation
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Shp2 function in neural stem cells Ke et al., page 3 suggests that Shp2 ablation does not completely block neural development from ESCs in mammals, yet the biological role of Shp2 in NSC activities and brain development has not been clearly defined.
In this study, we demonstrate that Shp2 is an important player during mammalian brain development, by generating a novel mutant mouse model with Shp2 selectively deleted in neural precursor cells. The conditional Shp2 knockout mice exhibited growth retardation and early postnatal lethality. We demonstrate functional requirements for Shp2 in self-renewing proliferation of NSCs, and neuronal and glial cell fate decisions. Our results provide a fresh view on molecular signaling mechanisms coordinating NSC self-renewal and cell lineage specification.

MATERIALS AND METHODS
Animals.
Mice were maintained at the Burnham Institute animal facility in accordance with NIH guidelines and approved by the Burnham Institute animal research committee.
Generation of a conditional Shp2 mutant allele (Shp2 flox ) was reported previously (40).
Generation and characterization of nestin-Cre1 and nestin-Cre2 transgenic mice were described elsewhere (11, 16).
Primary cortical tissue culture. Cerebral cortices were removed from E16.5 and P1 mice, and primary cortical neurons were prepared by trypsinization and mechanical dissociation as previously described (7). Glial cells were removed by preplating the isolated cortical cells suspended in DMEM supplemented with 10% FCS on uncoated culture plates. Neurons recovered as nonadherent cells were allowed to attach on poly-D-lysine or poly-DL-ornithine plus laminin coated cover glasses or culture dishes. The medium was replaced by B27 (Gibco) in Neurobasal medium (Gibco), and the cultures were incubated in 10% O2, 5% CO2 at 37 °C.
The neurons were incubated in Neurobasal medium without B27 for 4 hrs before growth factor stimulation (BDNF, 10 ng/ml; bFGF, 20 ng/ml; EGF, 20 ng/ml). Astrocytes and oligodendrocytes were cultured as previously described (23).
Immunohistochemistry, immunoblotting and in situ hybridization. The mice were anesthetized by avertin, perfused by PBS followed by 4% formaldehyde in PBS. The brain was removed, dehydrated, paraffin-sectioned or cryostat-sectioned. Incubation of primary and secondary antibodies was performed following standard protocols. Primary antibodies used were: rabbit anti-Shp2 polyclonal (Santa Cluz Biotechnology), mouse anti-nestin monoclonal (Rat 401 Hybridroma Bank), mouse anti-TuJ1 monoclonal (BABCO), rabbit anti-GFAP polyclonal (Sigma), mouse anti-MAP-2 monoclonal (Sigma), mouse anti-O4 monoclonal
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(Sigma), and mouse anti-CNPase monoclonal (Chemicon), rabbit anti-NG2 antibody (Chemicon), mouse anti-phosphorylated histone H3 (pH3) polyclonal (Upstate), anti-Ki67 polyclonal (Novo Castra), rabbit anti-cleaved Caspase 3 antibody (Cell Signaling), rabbit anti-Dab1 antibody (Cell Signaling), rabbit anti-p35 antibody (Santa Cruz biotechnology), rabbit anti-calbindin antibody (Cell Signaling). Preparation of cell/tissue lysates and immunoblot analysis with ECL detection were performed following standard protocols and the manufacturer's instruction. Primary antibodies used were: mouse anti-beta actin monoclonal (Sigma), rabbit anti-phospho-Erk polyclonal (Cell Signaling), rabbit anti-Erk polyclonal (Cell Signaling), rabbit anti-phospho-Erk 5 (Cell Signaling), rabbit anti-phospho-Erk5 (Cell Signaling), rabbit anti-phospho-Dab1 (Cell Signaling), rabbit anti-phospho-Stat3(Tyr705) polyclonal (Cell Signaling), rabbit anti-Stat3 polyclonal (Cell Signaling), rabbit anti-phospho-C/EBP beta polyclonal (Cell Signaling), rabbit anti-C/EBP polyclonal (Cell Signaling), anti-phospho-c-Myc (Cell Signaling), anti-c-Myc (Cell Signaling) and anti-Bmi-1 (Upstate Cell Signaling Solutions). RNA in situ hybridization was performed following a protocol previously described (1). The EphA4 probe was a gift from Dr.
Murai (McGill Univ.).
NSC culture and neurosphere assay. Cerebral cortices were dissected from E14.5 embryos and dissociated into single cells. Single cells were suspended and maintained in B27/Neurobasal medium supplemented with bFGF (20 ng/ml), EGF (20 ng/ml) and heparin (25 g/ml). Neurosphere assay was performed to determine self-renewal capacity in NSCs (22).
Briefly, spheres were dissociated into a single-cell suspension and reseeded in 96-well plate at low density (5,000 cells/ml, 200 l per well). The number and size of secondary or tertiary spheres were determined after 7 days. Neurospheres were counted under an optical microscope, with a minimum cutoff of 40 m diameter. A minimum of 12 wells (1000 single cells seeded
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per well originally) were counted, and the diameter of at least 10 randomly chosen neurospheres was determined using SimplePCI Advanced Image Capture (AIC) Software. MEK inhibitor PD98059 (Cell Signaling), c-Myc inhibitor 10058-F4 (Calbiochem), Shp2 inhibitor (Wu et al., unpublished data) were used at concentration of 25 µM in 0.05% DMSO, Stat3 inhibitor AG490 (Calbiochem) was used at concentration of 5µM in 0.01% DMSO.
Neuronal and astroglial differentiation. NSCs derived from E14.5 embryos or neurospheres were seeded at 20,000 cells/ml (20K) onto coverslips pre-coated with PDL (0.1 mg/ml) and laminin (20 g/ml) in serum-free B27/Neurobasal medium with no growth factors.
Cells were incubated in adhesion cultures for 5 days to allow neuronal differentiation. Addition of 2% FBS on day 5 enhanced neuronal differentiation and astroglial differentiation was examined 2 days later (on day 7).
Cell proliferation assays. Cell proliferation was assayed by a BrdU detection Kit (Roche). BrdU was added to the culture medium (final concentration, 10 M) and incubated for the desired time periods. Cells were fixed on coverslips and immunostained with a monoclonal anti-BrdU antibody followed by anti-mouse Ig-fluorescecin. Coverslips were mounted in VECTASHIELD mounting medium with DAPI (blue). BrdU + cells (FITC) and all cells (blue) were counted under a fluorescent microscope, and at least 10 fields were randomly chosen for counting. Cell growth curve was measured using the RT-CES TM system (Real Time Cell Electronic Sensing, ACEABIO) (17) . Briefly, primary NSCs were diluted and seeded at 4 cells/ml on laminin-PDL pre-coated ACEA's 96X microtiter plates in 200 µl of neurabasal/B27 medium. Cell proliferation was monitored in real time by RT-CES system for a period of 120 hrs, and the growth curve was analyzed with the RE-CES® 2.5 software. 
RESULTS
Deletion of Shp2 in Neural Stem/Progenitor Cells Leads to Early Postnatal Lethality
In previous experiments, we cloned the murine Shp2 (previously called Syp) cDNA, using a unique PCR strategy designed for search of SH2-containing tyrosine phosphases (9). In situ hybridization detected Shp2 expression in the neural ectoderm and nervous system in mouse embryos at embryonic day 9.5 (E9. Figure 1D ). In addition to loss of body weight, we observed development of abnormal behaviors in surviving pups after P4, particularly ataxia and the inability to suck milk. Multiple factors are likely to contribute to the early postnatal lethality phenotype.
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Shp2 Has a Positive Role in Corticogenesis
We did not observe a dramatic structural abnormality in the mutant brain. More detailed H & E staining however showed that lamination of the cortex was compromised in Shp2-deficient brain (Figure 2A) . We therefore examined cortical development and neuronal cell differentiation/migration using a variety of molecular markers. First, we investigated the expression of MAP2, a marker for dendrite-extended differentiated neurons. High levels of MAP2 expression were detected in the marginal zone and layer V in the control sections at P0, but the signals were weakened in the mutant ( Figure 2B ). This result suggests a possibly delayed and impaired neuronal differentiation.
Next, we checked EphA4 mRNA expression, a marker for layers II and III ( Figure 2C ).
As compared to controls at P0, almost no signal was detected in the mutant neocortex, which also implies a defective neuronal differentiation because EphA4 is expressed in postsynaptic regions. Another molecular marker, calbindin, is mainly expressed in layers III and IV. The staining was disorganized in the mutants, showing diffused layers III and IV ( Figure 2D ). We also examined reelin expression, a marker of Cajal-Retzius cells in layer I, and found no significant difference in localization and expression levels between wild-type controls and mutants (Supplemental Figure 2A) . No difference in Dab1 (E15.5) and p35 (P0) expression was recognized between controls and mutants (Supplemental Figures 2B, 2C ). We also treated cortical neurons isolated at E16.5 with reelin in vitro and checked phosphorylation of Dab1 at Tyr185 and Tyr220. No significant difference was detected between controls and mutants (Supplemental Figure 2D) . Together, these results suggest that ablation of Shp2 had
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influenced neuronal differentiation but not Reelin-induced cell migration during cortical development.
To further investigate the impact of Shp2 deletion on corticogenesis, we examined expression of several cell type-specific markers in cerebral cortex. Compared to controls, we detected reduced expression levels of neuronal marker (TuJ1) (Figure 2E) , and oligodendrocyte precursor marker (NG2) in the mutant brain ( Figure 2F ). In contrast, signals for astrocyte marker protein GFAP were enhanced at E16.5 ( Figure 2G ). These observations suggest a defective neurogenesis and oligodendrogenesis in cerebral cortex of the Shp2-deficient brain, while at the expense, astrogliogenesis appeared slightly enhanced.
Finally, we examined levels of phospho-histone H3 (pH3), a marker for metaphase, and Ki67, a proliferative maker, in the ventricular zone (VZ) of embryonic brain. As shown in Together, these results suggest that Shp2 promotes progenitor proliferation in corticogenesis.
Shp2 Oppositely Regulates Neurogenesis and Astrogliogenesis in vitro
The high level Shp2 expression in VZ suggests important roles of Shp2 in neural progenitor cells. To further investigate Shp2 function in NSC differentiation and multipotency, we isolated NSCs from cerebral cortex at E14.5 and cultured them in the presence of bFGF and EGF Figure 3D, 3E) , consistent with the in vivo results as described above. In contrast, we observed a modest increase in the proportion of astrocytes generated from Shp2-deficient NSCs, when compared to controls (Figure 3D, 3E) .
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However, the absolute number of GFAP + cells was similar between control and Shp2 mutant cultures ( Figure 3F) , apparently due to the reduced proliferative capacity of Shp2-deficent progenitor cells in the culture condition.
We further examined neurogenesis and gliogenesis from NSCs following treatment with growth factors or cytokines in vitro. As shown in Figure 3G , there was a significant decrease in the number of neurons from Shp2-deficient NSCs following stimulation with PDGF-BB, LIF or bFGF. In response to CNTF, Shp2 deficiency resulted in modestly decreased numbers of neurons (P > 0.05, n = 12). However, Shp2 ablation did not suppress gliogenesis in response to CNTF, LIF or bFGF, and there was a significant increase in the number of GFAP + cells following PDGF-BB treatment (* P < 0.05, n = 12). Collectively, our observations reveal a critical role for Shp2 in neurogenesis and oligodendrogenesis but not in astrogliogenesis. This
Shp2 function in neural stem cells Ke et al., page 13 indicates a cell type-specific requirement for Shp2 in neural development. The opposite effect of Shp2 deletion on neurogenesis and astrogliogenesis also suggests Shp2 actions in cell fate specification from multipotential progenitor cells.
Shp2 Is Required for Proliferation of NSCs and Neuronal Progenitors in vitro
We further investigated a putative role of Shp2 in NSC's self-renewal and proliferation potential in vitro. As depicted in Figure 4A , differences in the number and diameter of neurospheres derived from control and Shp2 -/-mutant NSCs were easily observed under a microscope. To further determine the impact of Shp2 deletion on self-renewal of NSCs, we assayed secondary and tertiary neurosphere formation efficiency. As shown in Figure 4B , Shp2-deficient NSCs exhibited a markedly decreased capacity to generate neurospheres following serial subcloning, suggesting impaired proliferation and/or self-renewal. Indeed, the self-renewal capacity, defined as the number of secondary neurospheres formed per primary neurosphere (2 0 /1 0 NS), was significantly reduced in Shp2 -/-NSCs when compared to controls.
Thus, Shp2 is required for self-renewal of NSCs in vitro ( Figure 4C ).
To determine the proliferative capacity, we measured growth curves of NSCs in culture conditions that favor either self-renewal or differentiation. When compared to controls, Shp2
-/-NSCs exhibited significantly decreased cell proliferation rate in culture conditions favoring selfrenewal expansion ( Figure 4D) . Similar proliferative defects of Shp2 -/-NSCs were also observed when the stem and progenitor cells were cultured in conditions allowing differentiation into neuronal and astroglial cell lineages ( Figure 4E ). To corroborate these results, we measured BrdU incorporation into cultured neurosphere cells under both self-renewal and differentiation conditions. Consistently, results presented in Figure 4F show that Shp2 
Shp2 Promotes Growth Factor Signals in NSCs
Our previous experiments indicate that despite a decreased proliferation rate, Shp2-deficient mouse embryonic stem cells (ESCs) exhibit enhanced self-renewal capacity, as reflected by the increased frequency of secondary embryonic body formation (4, 27) . This is in contrast to the observation of impaired self-renewal of Shp2-deficient NSCs as described above. To analyze the molecular basis for distinct functions of Shp2 in ESCs and NSCs, we conducted a comparative analysis of intracellular signaling between these two stem cell types in maintenance cultures ( Figure 5A ). We observed remarkably reduced levels of phospho-Erk1/2 in Shp2-deficient NSCs when compared to wild-type controls, but no significant difference was detected between wild-type and Shp2 mutant ESCs. Shp2 deficiency resulted in increased phosphoStat3 levels in both ESCs and NSCs and significantly decreased phospho-Akt in ESCs but not in NSCs. We also found that the phospho-C/EBP signal was significantly decreased in Shp2-deficient NSCs but not in ESCs. Together, these data suggest cell type-specific regulation of signaling pathways by Shp2, which could account for distinct phenotypes seen between Shp2-deficient ESCs and NSCs.
We then explored the possible involvement of Shp2 in relay of signals triggered by specific growth factors in NSCs. As previously reported, there are at least two cell populations in
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neurospheres, bFGF-responsive and EGF-dependent NSCs, and both growth factors synergize to promote proliferation (5, 35, 37). Thus, we examined the impact of Shp2 deletion on NSC responses to bFGF and/or EGF. Shp2 deficiency had a modest inhibitory effect on the number and size of neurospheres generated in the presence of EGF alone ( Figure 5B) . However, significantly decreased number and size of neurospheres were detected in Shp2-deficient NSCs, as compared to controls, in response to bFGF alone or bFGF plus EGF ( Figure 5B ). This result indicates a primary role of Shp2 in bFGF-dependent NSC proliferation and self-renewal. bFGF has been shown to maintain NSCs by promoting proliferation and suppressing differentiation in vitro and in vivo (26, 32, 34). Stimulation of NSCs by bFGF leads to rapid activation of Erk, whose suppression blocks proliferation of neural progenitors (19) . We observed that phosphoErk signals were much lower in Shp2-deficient NSCs than in controls in response to bFGF We also took a chemical biology approach to evaluate the effects of Erk, c-Myc and Stat3 activities in NSCs' self-renewal and neuronal/astroglial differentiation. NSCs were treated with
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pharmacological MEK inhibitor (PD98059) and c-Myc inhibitor (10058-F4), and were evaluated for self-renewal in neurosphere assay. As shown in Figure 5D , treatment with Erk or c-Myc inhibitors resulted in significantly reduced number of secondary neurospheres, indicating decreased self-renewal capacity. We also treated NSCs with PD98059, 10058-F4 and Jak2/Stat3 inhibitor (AG490) and subjected the cells to neuronal/astroglial differentiation. As depicted in Figure 5E & 5F, the MEK inhibitor suppressed neuronal differentiation, whereas cMyc inhibition had no effect. The Stat3 inhibitor significantly attenuated astroglial 
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Shp2 function in neural stem cells Ke et al., page 17
DISCUSSION
In this study, we generated and characterized mutant mouse strains with an intracellular tyrosine phosphatase Shp2 selectively deleted in neural precursor cells mediated by nestin-driven Cre expression. We observed a dramatic phenotype of growth retardation, early postnatal lethality and multiple defects in proliferation and cell fate specification in NSCs. Of note, we generated the conditional Shp2 knockout mice by using two nestin-Cre transgenic mouse lines independently created in two different laboratories, and consistent phenotypes were observed between Shp2 This study identifies unique intracellular signaling events underlying control of NSC activities. Shp2 is specifically required for NSC differentiation into neurons and oligodendrocytes but had a negative effect on astroglial differentiation. In mediating neurogenesis and astrogliogenesis, Shp2 appears to modulate Erk and Stat3 pathways in opposite directions. This result suggests that Shp2 participates in cell fate decisions of neural stem/progenitor cells during brain development. After submission of this manuscript, we
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Shp2 function in neural stem cells Ke et al., page 18 noticed a paper by Gauthier et al. reporting a similar effect of Shp2 tyrosine phosphatase in neuronal/astroglial cell fate decision observed by knockdown of Shp2 expression using the siRNA approach (10).
A common phenotype of Shp2-deficient ESCs and NSCs is reduced proliferative capacity.
However, a striking difference is that ESCs lacking functional Shp2 exhibit enhanced selfrenewal (4, 27), whereas this study presents data indicating that NSCs require Shp2 for self- also been shown to be required for proliferation and self-renewal of leukemic and hematopoietic stem cells in addition to neural stem cells (19, 25, 31) . Given that Shp2 also plays an essential role in regulating hematopoiesis and HSC activities, it is very likely that a common signaling pathway involving Shp2 and Bmi-1 operates in the self-renewal of both hematopoietic and neural stem cells. Nevertheless, it is conceivable that Shp2 acting in signaling events proximal to specific growth factor receptors may have multiple effects in signaling pathways.
Accordingly, we have noted a difference in the phenotypes of Shp2-deficient and Bmi-1-
deficient NSCs. Although both Shp2 and Bmi-1 are essential for NSC self-renewal and both inhibit astrogliogenesis, Bmi-1 deficiency has no significant effect on neurogenesis (22, 39), while loss of Shp2 leads to defective neurogenesis as reported here. Bmi-1-deficient mice survive into adulthood and show developmental retardation (22). However, Shp2 mutant mice die in the uterus (33), and mice with Shp2 selectively deleted in the brain exhibit early postnatal lethality, indicating that Shp2 has more extensive physiological effects than Bmi-1.
Identification of pathways altered in Shp2-deficient NSCs should further define the molecular basis for the control of NSC self-renewal and multipotentiality. 
(I) Significantly reduced numbers of pH3 + and Ki67 + cells were detected in Shp2 mutant VZ (pH3, ** P < 0.01, n = 6~7; Ki67, * P < 0.05 n = 3, mutant vs. control, scale bar: 100 m). 
Shp2 function in neural stem cells Ke et al., page 30 (F) Decreased numbers of TuJ1 + neurons differentiated from Shp2-deficient NSCs, when compared to controls (* P < 0.05, n = 5).
(G) NSC differentiation in response to various growth factors. NSCs were cultured at 2 X 10 4 cells/ml in Neurobasal/B27 serum-free medium, with a daily supplement of CNTF (100 ng/ml), PDGF-BB(100 ng/ml), LIF (3000 U/ml), bFGF (20 ng/ml) or None.
Differentiated cells were detected by immunostaining for TuJ1 and GFAP at day 5.
Shp2 deficiency resulted in reduced number of neurons following stimulation with PDGF, LIF, bFGF (** P < 0.01, * P < 0.05, n = 5), but caused significantly increased number of astrocytes following PDGF-BB treatment (* P < 0.05, n = 12). 
(E) Growth Curve of NSCs in differentiation culture. Single NSCs were seeded on precoated plate in absence of bFGF and EGF to induce neuronal differentiation, 2% FBS was added after 24 hrs to induce astroglial differentiation. Cell proliferation was monitored using the RT-CES TM system (17) . 
